Literature DB >> 90850

In-vivo platelet inhibition by piracetam.

R L Bick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 90850     DOI： 10.1016/s0140-6736(79)90689-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Use of piracetam improves sickle cell deformability in vitro and in vivo.

Authors:  E K Gini; J Sonnet
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

Review 2.  'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.

Authors:  A Spagnoli; G Tognoni
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

3.  Progressive Myoclonic Epilepsies.

Authors:  Basim M. Uthman; Andreas Reichl
Journal:  Curr Treat Options Neurol       Date:  2002-01       Impact factor: 3.598

4.  Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo.

Authors:  M Koskiniemi; B Van Vleymen; L Hakamies; S Lamusuo; J Taalas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.